Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma (Q79456671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

7

Hisao Asamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Yasufumi Kato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Koji Tsuta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kunihiko Seki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Akiko Miyagi Maeshima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Shunichi Watanabe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kenji Suzuki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ryosuke Tsuchiya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Yoshihiro Matsuno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

22 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

215-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17192790%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3800732

23 December 2019

exact match

0 references

cites work

Primary giant cell tumors of soft tissue

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Pathology of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

p53 expression is common in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesothelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Structure, function, and regulation of the mammalian facilitative glucose transporter gene family

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Expression of glucose transporters in head-and-neck tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Growth factors, mitogens, oncogenes and the regulation of glucose transport

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Facilitative glucose transporters

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

Application of metabolic-control logic to fuel utilization and its significance in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021

18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800732

7 January 2021